Associations Between Depression and Cardiovascular Disease - a Study of Patients With Late Onset Depression
NCT ID: NCT00818506
Last Updated: 2012-11-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
55 participants
OBSERVATIONAL
2009-03-31
2012-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Late onset MDD
Patients with major depressive disorder between 50 and 70 years of age that did not suffer from depression before the age of 50.
No interventions assigned to this group
Controls
Healthy controls (matched for age, sex, and tobacco use status)
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Meets the criteria for Major Depressive Disorder, Single Episode as defined in the Diagnostic and Statistical Manual, fourth edition (DSM-IV) and the International Classification of Diseases (ICD-10).
* Age 50-70 years.
* Written informed consent.
* Caucasian.
Exclusion Criteria
* Organic, including symptomatic, mental disorders as (ICD-10: F00-F09).
* Dependence syndrome within the last 5 years (ICD-10: F1x.2) or current harmful use (ICD-10: F1x.1) of alcohol or other psychoactive substances.
* Schizophrenia, schizotypal and delusional disorders (ICD-10: F20-F29).
* Subject to force of law according to the danish law on psychiatry.
* Present risk of suicide.
* Previous cranial trauma resulting in unconsciousness for more than 2 minutes.
* Medical history of renal failure.
* Other conditions which contraindicate specific procedures in the project.
* Other conditions deemed to prevent the subject from completing the examination program.
* Does not want to participate.
50 Years
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The Ministry of Science, Technology and Innovation, Denmark
OTHER_GOV
Vejle Hospital
OTHER
Danish National Research Foundation
OTHER
Aarhus University Hospital
OTHER
Augustinus Fonden
OTHER
University of Aarhus
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Poul Videbech, Professor, M.D., Dr.Med.
Role: STUDY_DIRECTOR
Center of Psychiatric Research, Aarhus University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Center of Psychiatric Research, Aarhus University Hospital
Aarhus, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CPF-TAD-1
Identifier Type: -
Identifier Source: org_study_id